bpc-157 fda status 2024 or 2025 panel backs compounded BPC-157, KPV peptides in win for RFK Jr FDA adcomm votes in favor
FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC 157 FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them RFK Jr. & claimed regenerative peptides like BPC 157 The Niche An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23


